ID   FM3A FUA169
AC   CVCL_D688
SY   FUA169; FUA 169
DR   Wikidata; Q54835259
RX   PubMed=7678417;
RX   PubMed=8420989;
CC   Characteristics: Compared to the parent cell line, shows a dramatic reduction in lactosylceramide (LacCer), the presence of a ganglioside GM3 and a high activity of CMP-sialic acid:LacCer 2,3-sialosyltransferase (PubMed=7678417).
CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
RX   PubMed=7678417; DOI=10.1016/S0021-9258(18)53983-1;
RA   Tsuruoka T., Tsuji T., Nojiri H., Holmes E.H., Hakomori S.-i.;
RT   "Selection of a mutant cell line based on differential expression of
RT   glycosphingolipid, utilizing anti-lactosylceramide antibody and
RT   complement.";
RL   J. Biol. Chem. 268:2211-2216(1993).
//
RX   PubMed=8420989; DOI=10.1016/S0021-9258(18)53984-3;
RA   Zheng M.-Z., Fang H., Tsuruoka T., Tsuji T., Sasaki T., Hakomori S.-i.;
RT   "Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin
RT   receptor for fibronectin-mediated adhesion of FUA169 cells.";
RL   J. Biol. Chem. 268:2217-2222(1993).
//